Dural ectasia in individuals with Marfan-like features but exclusion of mutations in the genes FBN1, TGFBR1 and TGFBR2
Standard
Dural ectasia in individuals with Marfan-like features but exclusion of mutations in the genes FBN1, TGFBR1 and TGFBR2. / Sheikhzadeh, S; Rybczynski, M; Habermann, C R; Bernhardt, A M J; Arslan-Kirchner, M; Keyser, B; Kaemmerer, H; Mir, T S; Staebler, A; Oezdal, N; Robinson, P N; Berger, J; Meinertz, T; von Kodolitsch, Y.
in: CLIN GENET, Jahrgang 79, Nr. 6, 06.2011, S. 568-574.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Dural ectasia in individuals with Marfan-like features but exclusion of mutations in the genes FBN1, TGFBR1 and TGFBR2
AU - Sheikhzadeh, S
AU - Rybczynski, M
AU - Habermann, C R
AU - Bernhardt, A M J
AU - Arslan-Kirchner, M
AU - Keyser, B
AU - Kaemmerer, H
AU - Mir, T S
AU - Staebler, A
AU - Oezdal, N
AU - Robinson, P N
AU - Berger, J
AU - Meinertz, T
AU - von Kodolitsch, Y
N1 - © 2010 John Wiley & Sons A/S.
PY - 2011/6
Y1 - 2011/6
N2 - Mutations in the genes FBN1, TGFBR1, and TGFBR2 can result in heritable connective tissue disorders comprising the Marfan syndrome and the Loeys-Dietz syndrome. Dural ectasia is a characteristic manifestation of both syndromes. However, dural ectasia has not yet been investigated in connective tissue disorders that are unrelated to mutations in the FBN1, TGFBR1 or TGFBR2 genes. Here, we assessed dural ectasia in 33 individuals both with typical manifestations of heritable connective tissue disease and in whom mutations in all three genes had been excluded. We identified 19 individuals with dural ectasia (58%), who exhibited major skeletal manifestations of the Marfan syndrome more frequently than the remaining 14 persons without dural ectasia (p = 0.06). Moreover, only persons with dural ectasia fulfilled clinical criteria of the Marfan syndrome (p = 0.01). Conversely, aortic aneurysm (12 patients; p = 0.8), aortic dissection (five patients; p = 0.1), spontaneous dissection of the carotid arteries (five patients; p = 1), and mitral valve prolapse (13 patients; p = 0.4) were similarly frequent irrespective of dural ectasia. We conclude that dural ectasia is a marker for connective tissue disease which coincides with skeletal rather than with cardiovascular manifestations, and which may involve currently uncharacterized pathogenetic mechanisms and syndromes.
AB - Mutations in the genes FBN1, TGFBR1, and TGFBR2 can result in heritable connective tissue disorders comprising the Marfan syndrome and the Loeys-Dietz syndrome. Dural ectasia is a characteristic manifestation of both syndromes. However, dural ectasia has not yet been investigated in connective tissue disorders that are unrelated to mutations in the FBN1, TGFBR1 or TGFBR2 genes. Here, we assessed dural ectasia in 33 individuals both with typical manifestations of heritable connective tissue disease and in whom mutations in all three genes had been excluded. We identified 19 individuals with dural ectasia (58%), who exhibited major skeletal manifestations of the Marfan syndrome more frequently than the remaining 14 persons without dural ectasia (p = 0.06). Moreover, only persons with dural ectasia fulfilled clinical criteria of the Marfan syndrome (p = 0.01). Conversely, aortic aneurysm (12 patients; p = 0.8), aortic dissection (five patients; p = 0.1), spontaneous dissection of the carotid arteries (five patients; p = 1), and mitral valve prolapse (13 patients; p = 0.4) were similarly frequent irrespective of dural ectasia. We conclude that dural ectasia is a marker for connective tissue disease which coincides with skeletal rather than with cardiovascular manifestations, and which may involve currently uncharacterized pathogenetic mechanisms and syndromes.
KW - Adolescent
KW - Adult
KW - Child
KW - DNA Mutational Analysis
KW - Diagnosis, Differential
KW - Dilatation, Pathologic/diagnosis
KW - Dura Mater/abnormalities
KW - Female
KW - Fibrillin-1
KW - Fibrillins
KW - Genetic Testing
KW - Humans
KW - Male
KW - Marfan Syndrome/diagnosis
KW - Microfilament Proteins/genetics
KW - Middle Aged
KW - Mutation
KW - Protein-Serine-Threonine Kinases/genetics
KW - Receptor, Transforming Growth Factor-beta Type I
KW - Receptor, Transforming Growth Factor-beta Type II
KW - Receptors, Transforming Growth Factor beta/genetics
KW - Sinus of Valsalva/abnormalities
KW - Young Adult
U2 - 10.1111/j.1399-0004.2010.01494.x
DO - 10.1111/j.1399-0004.2010.01494.x
M3 - SCORING: Journal article
C2 - 20662850
VL - 79
SP - 568
EP - 574
JO - CLIN GENET
JF - CLIN GENET
SN - 0009-9163
IS - 6
ER -